Cargando…

High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures

PURPOSE: Retinoblastomas are malignant eye tumors diagnosed in young children. Most retinoblastomas are genetically characterized by biallelic inactivation of the RB1 gene. However, 1.5% of tumors demonstrate high-level amplification of the proto-oncogene MYCN. Patients with MYCN-amplified RB1-profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roohollahi, Khashayar, de Jong, Yvonne, van Mil, Saskia E., Fabius, Armida W.M., Moll, Annette C., Dorsman, Josephine C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559112/ https://www.ncbi.nlm.nih.gov/pubmed/36245757 http://dx.doi.org/10.1016/j.xops.2022.100188

Ejemplares similares

Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN‐amplified retinoblastoma
por: Ewens, Kathryn G., et al.
Publicado: (2017)

Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
por: Zugbi, Santiago, et al.
Publicado: (2020)

MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma
por: Blixt, Maria K. E., et al.
Publicado: (2022)

Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes
por: Kooi, Irsan E., et al.
Publicado: (2016)

Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation
por: Saengwimol, Duangporn, et al.
Publicado: (2020)

Subsequent Malignant Neoplasms in Retinoblastoma Survivors
por: Fabius, Armida W. M., et al.
Publicado: (2021)

At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review
por: van Hoefen Wijsard, Milo, et al.
Publicado: (2021)

RB1 mutations and second primary malignancies after hereditary retinoblastoma
por: Dommering, Charlotte J., et al.
Publicado: (2011)

Optical coherence tomography (OCT) to image active and inactive retinoblastomas as well as retinomas
por: Nadiarnykh, Oleg, et al.
Publicado: (2019)

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression
por: Kooi, Irsan E., et al.
Publicado: (2015)

MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)

MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
por: Floros, Konstantinos V., et al.
Publicado: (2022)

Benign Tumors in Long-Term Survivors of Retinoblastoma
por: van Hoefen Wijsard, Milo, et al.
Publicado: (2021)

Feasibility of RetinoQuest: e-health application to facilitate and improve additional care for retinoblastoma survivors
por: McNeill, Nuray A., et al.
Publicado: (2017)

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
por: Misiak, Danny, et al.
Publicado: (2021)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
por: Tanimoto, Terutaka, et al.
Publicado: (2020)

MYCN-amplified neuroblastoma cell-derived exosomal miR-17-5p promotes proliferation and migration of non-MYCN amplified cells
por: Chen, Weiming, et al.
Publicado: (2021)

Multifocal intradural extramedullary ependymoma, MYCN amplified: illustrative case
por: Shields, Lisa B. E., et al.
Publicado: (2022)

FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2021)

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
por: Tan, Kezhe, et al.
Publicado: (2022)

RB116: An RB1+ retinoblastoma cell line expressing primitive markers
por: Bejjani, Anthony, et al.
Publicado: (2012)

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma
por: Liu, Tao, et al.
Publicado: (2022)

Targeting condensin, a vital spot of MYCN-amplified neuroblastoma
por: Tanno, Yuji, et al.
Publicado: (2014)

Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines
por: Dassi, Erik, et al.
Publicado: (2015)

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
por: Hald, Øyvind H., et al.
Publicado: (2018)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
por: Durbin, Adam D., et al.
Publicado: (2022)

RB1 gene inactivation by chromothripsis in human retinoblastoma
por: McEvoy, Justina, et al.
Publicado: (2014)

RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022)

Rb suppresses human cone precursor-derived retinoblastoma tumors
por: Xu, Xiaoliang L., et al.
Publicado: (2014)

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
por: Buechner, J, et al.
Publicado: (2011)

Genetic variation associated with childhood and adult stature and risk of MYCN‐amplified neuroblastoma
por: Semmes, Eleanor C., et al.
Publicado: (2020)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
por: Petrov, Ivan, et al.
Publicado: (2017)

Serine–glycine-one-carbon metabolism: vulnerabilities in MYCN-amplified neuroblastoma
por: Zhao, Erhu, et al.
Publicado: (2020)

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
por: Valind, Anders, et al.
Publicado: (2023)

The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma
por: Wang, Donghai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hrjmt0src4fll0ogcijnuqcmhl